Uji klinis Migrain di Nebraska
8 studi untuk Migrain mencari peserta di lokasi di Nebraska.
Kota di Nebraska
Teks studi resmi (Bahasa Inggris)
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Children's Hospital & Medical Center, Omaha
Menerima pesertaFase 1
Usia 6 hingga 11 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06995729Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Velocity Clinical Research, Grand Island, Grand Island
- Papillion Research Center/CCT Research, Papillion
Menerima pesertaFase 3
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT05156398Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Children's Hospital & Medical Center, Omaha
Menerima pesertaFase 3
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Children's Hospital & Medical Center, Omaha
Menerima pesertaFase 3
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT04649242A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Cct Research - Papillion Research Center /ID# 270393, Papillion
Menerima pesertaFase 3
Usia 12 hingga 17 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06810505Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Nebraska Medical Center, Omaha
Menerima pesertaFase 4
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Cognitive Clinical Trials (CCT) - Papillion /ID# 232552, Papillion
Menerima pesertaFase 3
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT05125302Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks
- Tri City Research Center, LLC /ID# 278800, Grand Island
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Feb 2026 · NCT07310290Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.